Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Liposome-nucleic acid immunotherapeutics.

Liposome-nucleic acid immunotherapeutics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Liposome-nucleic acid immunotherapeutics. Abstract Text:

    steven dowSteven Dow,

    Cationic liposome-nucleic acid complexes, which were originally developed for use as non-viral gene delivery vectors, may now have an equally important application as immunotherapeutic drugs. Recent studies have highlighted the ability of cationic liposomes to potently activate the innate immune system when used to deliver certain Toll-like receptor (TLR) agonists. The immune-enhancing properties of cationic liposomes have been most clearly demonstrated when combined with nucleic acid agonists for endosomally located TLRs, including TLR3, TLR7/8 and TLR9. Immune potentiation by cationic liposomes likely results from the combined effects of endosomal targeting, protection of nucleic acids from extracellular degradation, and from signaling via newly identified cytoplasmic receptors for nucleic acids. The potent innate immune stimulatory properties of liposome-nucleic acid complexes make them particularly attractive as non-specific immunotherapeutics and as vaccine adjuvants. Liposome-nucleic acid complexes have demonstrated impressive anticancer activity in a number of different animal tumor models. Moreover, liposome-nucleic acid complexes have also been shown to be effective for immunotherapy of acute viral and bacterial infections, as well as chronic fungal infections. When used as vaccine adjuvants, liposome-nucleic acid complexes target antigens for efficient uptake by dendritic cells and are particularly effective in eliciting CD8(+) T-cell responses to protein antigens. Thus, liposome-nucleic acid complexes form a potent and versatile immunotherapeutic platform.

    Liposome-nucleic acid immunotherapeutics. Publishing Authors By Initials

    s dowS Dow,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Liposome-nucleic acid immunotherapeutics. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Expert opinion on drug delivery

    VOLUME: 5

    Page Numbers: 11-24

    Journal Abbreviation:

    ISSN: 1742-5247

    DAY: 21

    MONTH: Jan

    YEAR: 2008

    Liposome-nucleic acid immunotherapeutics. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101228421

    Liposome-nucleic acid immunotherapeutics. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Liposome-nucleic acid immunotherapeutics. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Liposome-nucleic acid immunotherapeutics.

    AFFILIATION: Professor of Immunology Colorado State University, Department of Microbiology, Immunology, and Pathology, Ft. Collins, CO 80523, USA +1 970 491 6144 ; +1 970 491 0603 ; sdow@colostate.edu.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Opin Drug Deliv

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Liposome-nucleic acid immunotherapeutics Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News